Factor XIII Inhibitor Screen
Factor XIII is a coagulation protein that plays an important role in the stabilisation of a fibrin clot. Patients with FXIII deficiency can be treated with FXIII concentrate. It is possible that a patient can develop an antibody to the FXIII concentrate, thus affecting the efficacy of treatment.This test is used to screen for such antibodies.
|05 (CP) - Citrate
|Uses a Bethesda method read spectrophotometrically.
Chancellor / Lincoln Wing Link Corridor
St James University Hospital
|2 x Citrate tubes filled to line please.
Samples must be received & frozen within 6 hours of being taken.
|Ref. Range Notes
| If no inhibitor detected, this will be reported as NOT DETECTED. If present a bethesda unit will be reported
|Bethesda Units (BU)